Before 1987
A World Running Out of Antibiotics
The Invisible Crisis
Key moment
Frogs healed from surgery in bacteria-filled water — every time
By the 1980s, doctors were starting to worry. The antibiotics that had saved millions of lives since World War II were losing their power. Bacteria were learning to resist them. New superbugs appeared in hospitals. Drug companies were running out of new ideas.
Meanwhile, a quiet puzzle was hiding in plain sight. Scientists had been performing surgery on African clawed frogs for decades. These frogs were used in everything from pregnancy tests to genetics research. After surgery, they were placed back into tanks filled with murky, bacteria-laden water.
By all logic, these frogs should have been dying of infections. Their surgical wounds were open doors for germs. But the frogs healed perfectly. Every single time. Nobody stopped to ask why.
The Breakthrough
The Question Nobody Asked
A Surgeon Stops to Wonder
Key moment
Zasloff isolates magainins from frog skin — published 1987
Michael Zasloff had performed surgery on thousands of frogs during his career at the NIH. One day in 1986, as he watched a frog heal perfectly in its dirty tank, he stopped mid-step. A question hit him like a lightning bolt: Why don't these frogs ever get infected?
He did something brilliantly simple. He took pieces of frog skin, ground them up, and tested the mixture against bacteria. The bacteria died almost instantly.
Zasloff spent months purifying the active ingredients. He filtered, separated, and tested hundreds of fractions. Finally, he isolated two short peptides — tiny chains of just 23 amino acids. He named them magainins, from the Hebrew word 'magain,' meaning 'shield.'
In August 1987, he published his findings. The paper was a bombshell. Frog skin contained its own natural antibiotics — and they worked against bacteria, fungi, and even some viruses.
The Trials
The Shield Goes to War
From Frog Skin to Medicine Cabinet
Key moment
Pexiganan enters Phase III clinical trials for diabetic foot ulcers
Zasloff's discovery sparked intense excitement. If frogs made their own antibiotics, could we use them as drugs?
A company called Magainin Pharmaceuticals was founded to turn the discovery into medicine. Scientists created pexiganan (also called MSI-78) — a synthetic version of magainin-2 that was even more powerful than the natural version. It killed bacteria faster and at lower doses.
The target was diabetic foot ulcers. Millions of people with diabetes develop sores on their feet that get infected. When antibiotics fail, doctors sometimes have to amputate. Pexiganan could be applied directly to these wounds as a cream.
Phase III clinical trials enrolled thousands of patients. The medical world held its breath. This was the first antimicrobial peptide to make it this far in drug development. If it worked, it would prove that nature's ancient weapons could become modern medicine.
The Crisis
The Rejection
When the Shield Wasn't Enough
Key moment
FDA rejects pexiganan — devastating blow to the AMP field
In 1999, the results came in. And they were devastating.
Pexiganan worked. It killed bacteria in wounds. But it didn't work significantly better than existing antibiotic creams. The FDA advisory panel voted against approval. The dream was over.
For the entire field of antimicrobial peptide research, this was a crushing blow. Billions of dollars had been invested. Thousands of scientists had worked toward this moment. And the first peptide antibiotic to reach the FDA's door had been turned away.
Critics said antimicrobial peptides were too expensive, too fragile, and too similar to existing treatments to justify approval. Some scientists wondered if the whole field had been overhyped.
A second attempt at FDA approval was made in 2017 by a different company. It also faced challenges. Magainin-2's journey from frog skin to pharmacy shelf remained incomplete.
The Legacy
The Revolution That Mattered More
One Failure Launched a Thousand Breakthroughs
Key moment
3,000+ antimicrobial peptides discovered — all inspired by Zasloff's frogs
Here's what nobody predicted: the clinical failure didn't kill the field. It supercharged it.
Zasloff's 1987 frog skin paper became one of the most cited discoveries in immunology. Scientists around the world began searching for antimicrobial peptides everywhere — in human skin, in breast milk, in insects, in fish, in plants. Today, over 3,000 antimicrobial peptides have been discovered and studied.
Magainin-2 proved something far more important than any single drug. It proved that nature has been fighting bacteria with peptide weapons for over 500 million years. And those weapons still work — because bacteria struggle to develop resistance to them.
New peptide drugs based on magainin's principles are now in clinical trials for wound infections, superbugs, and even cancer. The field that started with one surgeon's curiosity about frog surgery has grown into a global research enterprise.
Michael Zasloff's question — 'Why don't these frogs get infected?' — turned out to be one of the most important questions in modern medicine.
Peptide history · 1987
Magainin-2 Antimicrobial Peptide
The Frog Skin Shield That Launched a Revolution
When a surgeon at the NIH noticed that his lab frogs never got infections after surgery — even in filthy water — he uncovered an ancient weapon hidden in their skin. His discovery didn't just find a new antibiotic. It launched an entirely new field of medicine.
Isolated from African clawed frog skin
Short alpha-helical peptide
Daltons
African clawed frog
Means 'shield'
Compound classification
Dr. Michael Zasloff
The Frog Whisperer · National Institutes of Health (NIH)
Zasloff was a surgeon performing operations on African clawed frogs when he noticed something extraordinary: the frogs never got infected after surgery, even when placed back into bacteria-filled water. In 1987, he isolated magainins from their skin — launching the entire modern field of antimicrobial peptide research.
I must have performed surgery on thousands of frogs over the years. Not once did I see a post-operative infection. One day I stopped and asked myself: Why not?
Dr. Robert Lehrer
The Defensin Pioneer · UCLA
Lehrer's earlier work on mammalian defensins provided the scientific framework that helped contextualize Zasloff's discovery. His research showed that antimicrobial peptides weren't unique to frogs — they were a universal defense strategy found across all life on Earth.
When Zasloff's paper came out, it confirmed what many of us suspected: nature had been making antibiotics long before we invented penicillin.
Dr. Hans G. Boman
The Insect Immunity Pioneer · Stockholm University
Boman's 1981 discovery of cecropins in silk moths laid the groundwork for Zasloff's frog skin research. Together, their work proved that antimicrobial peptides are an ancient, universal defense system spanning insects, amphibians, and mammals.
Nature has been perfecting antimicrobial weapons for hundreds of millions of years. Frogs, moths, humans — we all carry them.
13 milestones, 1972 – 2024.
- 1972Hans Boman discovers antimicrobial activity in silk moth pupae
- 1981Cecropin isolated from insects — first animal antimicrobial peptide
- 1986Zasloff notices frogs never get infected after surgery at NIH
- 1987Magainins isolated from African clawed frog skin — published in PNAS
- 1987Named from Hebrew 'magain' meaning shield
- 1988Magainin Pharmaceuticals founded to develop peptide drugs
- 1992Pexiganan (MSI-78) synthetic analog created with enhanced potency
- 1995Phase II clinical trials of pexiganan for diabetic foot ulcers
- 1997Phase III trials completed with thousands of patients
- 1999FDA rejects pexiganan — major setback for the field
- 2003Over 1,000 antimicrobial peptides cataloged in databases
- 2017Second FDA application attempt for pexiganan by Dipexium
- 20243,000+ antimicrobial peptides discovered — magainin's legacy grows
Imagine a tiny sword that has two sides — one oily, one electrically charged. When bacteria appear, this sword spins into a coil, grabs onto the bacterial wall with its oily side, and punches through with its charged side. The bacterium pops open like a water balloon.
Molecular structure
- Amino Acids
- 23
- Molecular Weight
- 2,467 Da
- Structure
- Alpha-helix (coiled)
- Net Charge
- +4 (positive)
- Source Organism
- Xenopus laevis
- Sequence
- GIGKFLHSAKKFGKAFVGEIMNS
All inspired by Zasloff's frog skin research
Tiny but incredibly powerful
Antimicrobial peptides predate the dinosaurs
Global research effort launched by one observation
Real stories, real lives
Dr. Lisa Hernandez
I entered the antimicrobial peptide field because of Zasloff's frog paper. It was the most elegant discovery I'd ever read — a surgeon stops, looks at a frog, and asks a question nobody else bothered to ask. That's what science is supposed to be. Today I study peptide-based wound treatments, and every day I think about those frogs.
Robert Kim
I've had three foot ulcers in five years. Each time, the antibiotics barely worked. When I heard about peptide-based wound treatments inspired by frog skin, I thought it was a joke. But the science is real. Nature figured out how to fight infections millions of years ago. I hope we can use that knowledge before I lose a toe.
The future of Magainin-2
- Next-Generation PexigananPreclinical
Redesigned magainin analogs with better stability and stronger killing power for wound infections
- Anti-Superbug PeptidesResearch
Magainin-inspired peptides designed to fight drug-resistant bacteria that traditional antibiotics can't kill
- Cancer-Fighting PeptidesEarly Research
Modified magainins that target cancer cell membranes, which have different charges than normal cells
- Combination TherapiesPreclinical
Pairing magainin-based peptides with traditional antibiotics to boost their effectiveness against resistant bacteria
Be inspired
The story of Magainin-2 is ultimately about the relentless pursuit of better medicine for humanity.
Continue the legacy. The next breakthrough could be yours.